Professor Stephen Boppart's Biophotonics Imaging Laboratory is focused on developing novel optical biomedical diagnostic and imaging technologies, and translating them into clinical applications. He is one of the early developers of the OCT technology, and is actively participating in the growth, application, and clinical adoption of this technology, including applications in cancer imaging, primary care imaging, and the design and development of novel contrast agents specifically for OCT. Professor Boppart completed his Ph.D. in Medical and Electrical Engineering from MIT, and his M.D. from Harvard Medical School. He has over 200 invited and contributed publications and over 30 patents related to optical biomedical imaging technology. He has mentored over 80 undergraduate, graduate, and post-graduate interdisciplinary researchers. He was recognized by MIT's Technology Review Magazine as one of the Top 100 Young Innovators in the World for his development of medical technology, received the IEEE Engineering in Medicine and Biology Early Career Award, and recently, the Paul F. Forman Engineering Excellence Award from the Optical Society of America for dedication and advancement in undergraduate research education. He was Founding Director of the Mills Breast Cancer Institute at Carle Foundation Hospital, Urbana, Illinois, and has worked to establish partnership ties between the University of Illinois and local medical institutions. He is a Fellow of IEEE, the Optical Society of America (OSA), and SPIE. Currently he holds a Bliss Professorship of Engineering and is Director of a campus-wide Illinois Imaging Initiative to integrate imaging science, technology, and applications across multiple modalities and fields.

See also here